Next Article in Journal
The Combination of Chitosan-Based Biomaterial and Cellular Therapy for Successful Treatment of Diabetic Foot—Pilot Study
Previous Article in Journal
Anti-HER2 Cancer-Specific mAb, H2Mab-250-hG1, Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab
Previous Article in Special Issue
Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2024, 25(15), 8387; https://doi.org/10.3390/ijms25158387
Action Date Notes Link
article xml file uploaded 1 August 2024 06:29 CEST Original file -
article xml uploaded. 1 August 2024 06:29 CEST Update https://www.mdpi.com/1422-0067/25/15/8387/xml
article pdf uploaded. 1 August 2024 06:29 CEST Version of Record https://www.mdpi.com/1422-0067/25/15/8387/pdf
article supplementary file uploaded. 1 August 2024 06:29 CEST - https://www.mdpi.com/1422-0067/25/15/8387#supplementary
article html file updated 1 August 2024 06:30 CEST Original file https://www.mdpi.com/1422-0067/25/15/8387/html
Back to TopTop